[1]
Jingjing Fan, Yi Liu, Xie Xuping, Bo Zhang, Zhiming Yuan, 2013: Inhibition of Japanese Encephalitis Virus Infection by Flavivirus Recombinant E Protein Domain Ⅲ, Virologica Sinica, 28, 152-160. doi: 10.1007/s12250-013-3331-8
[2]
Tong Lin, Jing Li, Jun-jun Shao, Guo-zheng Cong, Jun-zheng Du, Shan-dian Gao, Hui-yun Chang, 2011: Develope Monoclonal Antibody against Foot-and-mouth Disease Virus A Type ^*, Virologica Sinica, 26, 273-278. doi: 10.1007/s12250-011-3199-4
[3]
张春涛, 李秀华, 宋爱京, 许四宏, 王佑春*, 2005: The Relationship of the Nucleic Acid and Antibody of HIV/HCV Among Drug Users, Virologica Sinica, 20, 600-602.
[4]
Bingxin Zhao, Xiaoxia Pan, Yumei Teng, Wenyue Xia, Jing Wang, Yuling Wen, Yuanding Chen, 2015: Rotavirus VP7 epitope chimeric proteins elicit cross-immunoreactivity in guinea pigs, Virologica Sinica, 30, 363-370. doi: 10.1007/s12250-015-3620-5
[5]
Shouli Wu, Min Gao, Jian Zheng, Pingping Yan, Wei Wang, Xiaoli Lu, Yuefeng Qiu, Yansheng Yan, 2019: Prevalence of HIV Indeterminate Western Blot Tests and Follow-up of HIV Antibody Sero-Conversion in Southeastern China, Virologica Sinica, 34, 358-366. doi: 10.1007/s12250-019-00130-3
[6]
Shuai SONG, Tong LIN, Jun-jun SHAO, Shan-dian GAO, Guo-zheng CONG, Jun-zheng DU, Hui-yun CHANG, 2009: Preparation and Characterization of Monoclonal Antibodies against VP1 Protein of Foot-and-mouth Disease Virus O/China99, Virologica Sinica, 24, 566-572. doi: 10.1007/s12250-009-3061-0
[7]
Wenyi Guan, Wendong Lan, Jing Zhang, Shan Zhao, Junxian Ou, Xiaowei Wu, Yuqian Yan, Jianguo Wu, Qiwei Zhang, 2020: COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine, Virologica Sinica, 35, 685-698. doi: 10.1007/s12250-020-00297-0
[8]
李春英, 吕春兰, 喻东威, 张利平, 赛文, 吴秉仁, 2000: Study on Human Cytomegalovirus(HCMV)Infection in the Blood Donors, Virologica Sinica, 15, 111-115.
[9]
Xi Liu, Li Ding, Jing Yuan, Jian Liao, Lian Duan, Wenfei Wang, Weiguo Tan, Weiye Yu, Boping Zhou, Xinchun Chen, Zheng Yang, 2019: Identification of a Novel Universal Potential Epitope on the Cytoplasmic Tail of H7N9 Virus Hemagglutinin, Virologica Sinica, 34, 334-337. doi: 10.1007/s12250-019-00110-7
[10]
Ling Ma, Shumin Chen, Zhen Wang, Saisai Guo, Jianyuan Zhao, Dongrong Yi, Quanjie Li, Zhenlong Liu, Fei Guo, Xiaoyu Li, Pingping Jia, Jiwei Ding, Chen Liang, Shan Cen, 2021: The CREB Regulated Transcription Coactivator 2 Suppresses HIV-1 Transcription by Preventing RNA Pol Ⅱ from Binding to HIV-1 LTR, Virologica Sinica, 36, 796-809. doi: 10.1007/s12250-021-00363-1
[11]
Zhenyuan Wang, Chunjun Qin, Jing Hu, Xiaoqiang Guo, Jian Yin, 2016: Recent advances in synthetic carbohydrate-based human immunodeficiency virus vaccines, Virologica Sinica, 31, 110-117. doi: 10.1007/s12250-015-3691-3
[12]
Chinwe O. Ewenighi-Amankwah, Charles Chinedum Onyenekwe, Ogochukwu Udemba, Patience Muogbo, Lijun Rong, 2020: A Mother-to-Child Transmission Study in Nigeria: The Impact of Maternal HIV Infection and HAART on Plasma Immunoglobulins, Cytokine Profiles and Infant Outcome, Virologica Sinica, 35, 468-477. doi: 10.1007/s12250-020-00202-9
[13]
Yan Yan, Yong Ren, Renfang Chen, Jing Hu, Yongjia Ji, Junyang Yang, Jiayin Shen, Lvyin Hu, Hao Pei, Jun Wang, Yuanwang Qiu, Hongzhou Lu, Lihua Huang, 2018: Evaluation of Epstein-Barr Virus Salivary Shedding in HIV/AIDS Patients and HAART Use: A Retrospective Cohort Study, Virologica Sinica, 33, 227-233. doi: 10.1007/s12250-018-0028-z
[14]
Xue-qing Chen, Chang Liu, Xiao-hong Kong, 2011: The Role of HIV Replicative Fitness in Perinatal Transmission of HIV, Virologica Sinica, 26, 147-155. doi: 10.1007/s12250-011-3180-2
[15]
Yanpeng Li, Ulf Dittmer, Yan Wang, Jiping Song, Binlian Sun, Rongge Yang, 2016: The V1 region of gp120 is preferentially selected during SIV/HIV transmission and is indispensable for envelope function and virus infection, Virologica Sinica, 31, 207-218. doi: 10.1007/s12250-016-3725-5
[16]
Krystelle Nganou-Makamdop, Daniel C. Douek, 2019: Manipulating the Interferon Signaling Pathway: Implications for HIV Infection, Virologica Sinica, 34, 192-196. doi: 10.1007/s12250-019-00085-5
[17]
Lei KANG, Jing HU, Xue-shan XIA, Jian-guo WU, 2007: HIV and HCV: from Co-infection to Epidemiology, Transmission, Pathogenesis, and Treatment, Virologica Sinica, 22, 443-450.
[18]
Yan JIANG, 2007: Development and Challenge of HIV/AIDS Testing Laboratory Network and Quality Assurance System in China, Virologica Sinica, 22, 434-442.
[19]
Xin Chen, Mei Ye, Yu Wang, Chiyu Zhang, Yong-Tang Zheng, 2020: Laos is Affected by HIV CRF01_AE and the Newly Identified CRF97_01B, Virologica Sinica, 35, 538-547. doi: 10.1007/s12250-020-00215-4
[20]
Eman Teer, Danzil E. Joseph, Richard H. Glashoff, M.Faadiel Essop, 2021: Monocyte/Macrophage-Mediated Innate Immunity in HIV-1 Infection: From Early Response to Late Dysregulation and Links to Cardiovascular Diseases Onset, Virologica Sinica, 36, 565-576. doi: 10.1007/s12250-020-00332-0